Downregulation of GSK3β with siRNA or with chemical inhibitors decreased an activity of NF-κB which in turn resulted in a decreased GBM cell survival in vitro and inhibition of tumor growth in vivo [45, 56]. Here, GSK3B is linked to glioblastoma.